FONDAZIONE TELETHON ETS
Updates & Highlights
FDA Approves Waskyra as First Gene Therapy for Wiskott-Aldrich Syndrome
FDA Approves Waskyra as First Gene Therapy for Wiskott-Aldrich Syndrome - Read more on CGTLive®
CGTLive® · 2 months ago
FDA Greenlights First Gene Therapy for Rare Pediatric Disease
FDA Greenlights First Gene Therapy for Rare Pediatric Disease - Read more on BioSpace
BioSpace · 2 months ago
FDA clears first gene therapy for rare genetic disease WAS
FDA clears first gene therapy for rare genetic disease WAS - Read more on pharmaphorum
pharmaphorum · 2 months ago
Recent Openings
View all 1 jobsCulture & Mission
Fondazione Telethon ETS is building innovative AI solutions with a focus on collaboration and excellence. Join a team of talented engineers working on cutting-edge technology.
Office-Based
Benefits & Perks
🏥
Health Insurance
Medical, dental & vision
🏠
Remote Work
Work from anywhere flexibility
📚
Learning Budget
Professional development
💰
Competitive Salary
Market-rate compensation
📈
Equity/Stock Options
Ownership in the company
🏖️
Generous PTO
Paid time off
Tech Stack
Data Science Ai
Core Values
🎯
Innovation
Pushing boundaries in AI/ML technology
🤝
Collaboration
Working together to achieve more
⚡
Excellence
Striving for the highest quality
🌍
Impact
Making a difference in the world
Office Locations
Milano, LOM, IT
Milano
IT
Team
Team information coming soon